Osteoradionecrosis in head-and-neck cancer has a distinct genotype-dependent cause

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages 1479-1484

  Lyons, Andrew J ^a   West, Catharine M ^b   Risk, Janet M ^c   Slevin, Nick J ^d   Chan, Clara ^d   Crichton, Siobhan ^e   Rinck, Gabrielle ^f   Howell, Dawn ^f   Shaw, Richard J ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d CHRISTIE HOSPITAL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f Laboratory 21   (United Kingdom)

Author keywords

Genotype; Head and neck cancer; Osteoradionecrosis; Post radiotherapy; Transforming growth factor 1; Variant allele

Indexed keywords

GENOTYPE; HEAD-AND-NECK CANCER; OSTEORADIONECROSIS; POST-RADIOTHERAPY; TRANSFORMING GROWTH FACTORS; VARIANT ALLELE;

DISEASES; RADIOTHERAPY;

GENES;

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALLELE; ARTICLE; BONE NECROSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; DENTOALVEOLAR SURGERY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENOTYPE; HEAD AND NECK CANCER; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OSTEORADIONECROSIS; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84857923675     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.016     Document Type: Article

References (32)

1. Regaud C. Sur la necrose des os attent par un processus cancereux et traites par les radiaions. Compt Rend Soc Biol 1922;87:629; Oral Surg 1951;4:1951.
2. G. Store, and M. Boysen Mandibular osteoradionecrosis: Clinical behaviour and diagnostic aspects Clin Otolaryngol Allied Sci 25 2000 378 384
3. M. Harris The conservative management of osteoradionecrosis of the mandible with ultrasound therapy Br J Oral Maxillofac Surg 30 1992 313 318
4. M.S. Teng, and N.D. Futran Osteoradionecrosis of the mandible Curr Opin Otolaryngol Head Neck Surg 13 2005 217 221
5. J.K. Wong, R.E. Wood, and M. McLean Conservative management of osteoradionecrosis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 1997 16 21
6. A. Lyons, and N. Ghazali Osteoradionecrosis of the jaws: Current concepts of its pathophysiology and treatment Br J Oral Maxillofac Surg 46 2008 653 660
7. E.V. Kluth, P.R. Jain, and R.N. Stuchell A study of factors contributing to the development of osteoradionecrosis of the jaws J Prosthet Dent 59 1988 194 201
8. T. Kuhnt, A. Becker, and M. Bloching Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors Med Oncol 23 2006 325 334
9. N. Stafford, J. Waldron, and D. Davies Complications following fast neutron therapy for head and neck cancer J Laryngol Otol 106 1992 144 146
10. G. Studer, S.P. Studer, and R.A. Zwahlen Osteoradionecrosis of the mandible: Minimized risk profile following intensity-modulated radiation therapy (IMRT) Strahlenther Onkol 182 2006 283 288
11. T. Chang, P.R. Sandow, and C.G. Morris Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible Head Neck 29 2007 528 536
12. J.J. Thorn, H.S. Hansen, and L. Specht Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation J Oral Maxillofac Surg 58 2000 1088 1093
13. R. Marx Osteoradionecrosis: A new concept of its pathophysiology J Oral Maxillofac Surg 41 1983 283-288
14. S. Delanian, and J.L. Lefaix The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway Radiother Oncol 73 2004 119 131
15. K. Randall, and J.E. Coggle Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage Int J Radiat Biol 68 1995 301 309
16. J. Gauldie, T. Galt, and P. Bonniaud Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia Am J Pathol 163 2003 2575 2584
17. B. O'Sullivan, and W. Levin Late radiation-related fibrosis: Pathogenesis, anifestations, and current management Semin Radiat Oncol 13 2003 274 289
18. C. Mauch, and T. Kreig Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis Rheum Dis Clin North Am 16 1990 93 107
19. M. Martin, J. Lefaix, and S. Delanian TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47 2000 277 290
20. M.S. Anscher, F.M. Kong, and L.B. Marks Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis Int J Radiat Oncol Biol Phys 37 1997 253 258
21. S. Quarmby, H. Fakhoury, and E. Levine Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients Int J Radiat Biol 79 2003 137 143
22. C.N. Andreassen, J. Alsner, and J. Overgaard TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer Radiother Oncol 75 2005 18 21
23. F.M. Kong, X. Ao, and L. Wang The use of blood biomarkers to predict radiation lung toxicity: A potential strategy to individualize thoracic radiation therapy Cancer Control 15 2008 140 150
24. M.S. Anscher Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy Oncologist 15 2010 350 359
25. R. Giotopoulos, P. Symonds, and K. Foweraker The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes Br J Cancer 96 2007 1001 1007
26. R. Shah, C.K. Hurley, and P.E. Posch A molecular mechanism for differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c.-1347C > T) Hum Genet 120 2006 461 469
27. R.E. Marx, and R.P. Johnson Studies in the radiobiology of osteoradionecrosis and their clinical significance Oral Surg Oral Med Oral Pathol 64 1987 379 390
28. G. Marinello, J.F. Wilson, and B. Pierquin The guidegutter or loop techniques of interstitial implantation and the Paris system of dosimetry Radiother Oncol 4 1985 265 274
29. G.C. Barnett, C.M. West, and A.M. Dunning Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype Nat Rev Cancer 9 2009 134 142
30. J.S. Brown, T.K. Blackburn, and J.A. Woolgar A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy Oral Oncol 43 2007 764 773
31. R.E. Marx, R.P. Johnson, and S.N. Kline Prevention of osteoradionecrosis: A randomized prospective clinical trial of hyperbaric oxygen versus penicillin J Am Dent Assoc 111 1985 49 54
32. S. Delanian, J. Depondt, and J.L. Lefaix Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: A phase II trial Head Neck 27 2005 114 123